Literature DB >> 19319607

Positron emission tomography in mesothelioma patients.

Gaia Grassetto, Domenico Rubello.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19319607     DOI： 10.1007/s11307-009-0210-7

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN： 1536-1632            Impact factor:   3.488


× No keyword cloud information.
  19 in total

1.  The role of PET in the surgical management of malignant pleural mesothelioma.

Authors:  Raja M Flores
Journal:  Lung Cancer       Date:  2005-04-14       Impact factor: 5.705

2.  Positron emission tomography with f18-fluorodeoxyglucose in the staging and preoperative evaluation of malignant pleural mesothelioma.

Authors:  D B Schneider; C Clary-Macy; S Challa; K C Sasse; S H Merrick; R Hawkins; G Caputo; D Jablons
Journal:  J Thorac Cardiovasc Surg       Date:  2000-07       Impact factor: 5.209

Review 3.  [18-Fluoro-deoxy-glucose (15FDG) positon emission tomography (PET) for the evaluation of malignant pleural disease].

Authors:  M Meignan; G Paone
Journal:  Rev Pneumol Clin       Date:  2006-04

Review 4.  Morphologic and functional imaging of malignant pleural mesothelioma.

Authors:  Masaki Yamamuro; Victor H Gerbaudo; Ritu R Gill; Francine L Jacobson; David J Sugarbaker; Hiroto Hatabu
Journal:  Eur J Radiol       Date:  2007-10-22       Impact factor: 3.528

5.  Current state and future directions of pleural mesothelioma imaging.

Authors:  Samuel G Armato; James Entwisle; Mylene T Truong; Anna K Nowak; Giovanni Luca Ceresoli; Binsheng Zhao; Ripen Misri; Hedy L Kindler
Journal:  Lung Cancer       Date:  2007-12-03       Impact factor: 5.705

Review 6.  Malignant pleural mesothelioma: utility of 18 F-FDG PET.

Authors:  Maria Grazia Spitilli; Giorgio Treglia; Maria Lucia Calcagni; Alessandro Giordano
Journal:  Ann Ital Chir       Date:  2007 Sep-Oct       Impact factor: 0.766

7.  Potential of dual time point FDG-PET imaging in differentiating malignant from benign pleural disease.

Authors:  Ayse Mavi; Sandip Basu; Tevfik F Cermik; Muammer Urhan; Mehdi Bathaii; Dhurairaj Thiruvenkatasamy; Mohamed Houseni; Simin Dadparvar; Abass Alavi
Journal:  Mol Imaging Biol       Date:  2009-05-27       Impact factor: 3.488

8.  Role of 18F-FDG PET for evaluating malignant pleural mesothelioma.

Authors:  Cristina Nanni; Paolo Castellucci; Mohsen Farsad; Carmine Pinto; Andrea Moretti; Cinzia Pettinato; Mario Marengo; Stefano Boschi; Roberto Franchi; Andrea Martoni; Nino Monetti; Stefano Fanti
Journal:  Cancer Biother Radiopharm       Date:  2004-04       Impact factor: 3.099

9.  PET for the evaluation of pleural thickening observed on CT.

Authors:  Henk Kramer; Remge M Pieterman; Dirk-Jan Slebos; Wim Timens; Willem Vaalburg; Gerard H Koëter; Harry J M Groen
Journal:  J Nucl Med       Date:  2004-06       Impact factor: 10.057

10.  Assessment of malignant pleural mesothelioma with (18)F-FDG dual-head gamma-camera coincidence imaging: comparison with histopathology.

Authors:  Victor H Gerbaudo; David J Sugarbaker; Scott Britz-Cunningham; Marcelo F Di Carli; Charles Mauceri; S Ted Treves
Journal:  J Nucl Med       Date:  2002-09       Impact factor: 10.057
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.